Cornelis J. Pronk

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Correlation Between Kidney Size and Lean Body Mass in Survivors of Childhood and Young Adult Acute Lymphoblastic Leukemia.

Correlation Between Kidney Size and Lean Body Mass in Survivors of Childhood and Young Adult Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer

Published: April 21, 2026

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Journal: Trials

Published: February 13, 2026

Glucarpidase efficacy in mitigating methotrexate toxicity is unaffected by concurrent administration of folinic acid.

Glucarpidase efficacy in mitigating methotrexate toxicity is unaffected by concurrent administration of folinic acid.

Journal: Cancer chemotherapy and pharmacology

Published: December 12, 2025

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse.

Journal: Pediatric blood & cancer

Published: December 10, 2025

Etiology of apneic episodes in infants aged <1 year and validation of brief resolved unexplained events risk-stratification criteria without age as a risk factor.

Etiology of apneic episodes in infants aged <1 year and validation of brief resolved unexplained events risk-stratification criteria without age as a risk factor.

Journal: Frontiers in pediatrics

Published: October 23, 2025

Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments.

Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments.

Journal: Journal of internal medicine

Published: August 08, 2025

Population-Based Study Found Low Risk of Misdiagnosing Long QT Syndrome as Breath-Holding Spells in Swedish Children.

Population-Based Study Found Low Risk of Misdiagnosing Long QT Syndrome as Breath-Holding Spells in Swedish Children.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: May 18, 2025

iPSCs unlock clues to pediatric AML onset.

iPSCs unlock clues to pediatric AML onset.

Journal: Blood

Published: April 03, 2025

Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia.

Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia.

Journal: Haematologica

Published: January 20, 2025

Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation.

Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation.

Journal: Transplantation proceedings

Published: January 03, 2025

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Journal: Nature communications

Published: June 07, 2024

Guidelines for uniform management of breath-holding spells

Guidelines for uniform management of breath-holding spells

Journal: Lakartidningen

Published: June 05, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026